Subsequent campaigns
Subsequent introductions will be country-driven and coordinated under WHO leadership
The goal is to protect all children who are at-risk of contracting meningitis A. |
Introduction in other core countries, bordering countries, or at-risk countries will be based on a review of the priority criteria by the International Coordinating Group (ICG) on Vaccine Provision for Epidemic Meningitis Control, the entity that is currently managing emergency polysaccharide vaccine stockpiles.
Specifically, a process has been developed under WHO leadership that starts with an AFRO/GAVI subcommittee review of country proposals and a submission of their recommendations to ICG, where final decisions on country selection will be made. The process is a country-driven approach recognizing the epidemiologic context and the ability of the country to mount vaccination campaigns.
The table below shows the WHO proposed rollout plan for MenAfriVac™ in the countries of the African meningitis belt after the initial introduction of the vaccine in Burkina Faso, Mali, and Niger.
 |
Photo: Monique Berlier.
